Yes, nephritis can significantly impact cancer treatment. Nephrotoxic effects of certain cancer therapies may necessitate dose adjustments or discontinuation of the offending agent, potentially compromising the effectiveness of cancer treatment. Moreover, impaired kidney function can affect the metabolism and excretion of chemotherapeutic drugs, increasing the risk of toxicity. Therefore, close monitoring and proactive management of nephritis are essential to optimize cancer treatment outcomes while minimizing kidney damage.
